INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2023, Number 2

Cardiovasc Metab Sci 2023; 34 (2)

Left atrial myxoma: the importance of cardiovascular imaging in the long-term follow-up of breast cancer survivors

Alanís-Naranjo, José Martín; Galeana-Abarca, Cielmar; Rentería-Galicia, Marco Antonio; Arroyo-Martínez, Esbeidira Aranet; Loredo-Alanís, María Azalea; Rodríguez-López, Thelma

ABSTRACT

The incidence of cancer patients with cardiac diseases requiring surgery is rising as the population ages, and early detection of cancer and the use of new therapies are increasing survival rates. Cardiac tumors, despite their rarity, are an integral part of the cardio-oncology practice and require diagnosis and treatment. In recent years, the incidence of cardiac tumors has risen due to advancements in multimodality imaging, which have become more accessible and widespread. The association between treated breast cancer and myxoma could be considered a mere coincidence, but a few documented cases exist. We report the case of a patient with a history of breast cancer who presented, upon follow-up, a left atrial cardiac mass on cardiovascular imaging and underwent immediate surgery. This case illustrates the importance of Cardio-Oncology Clinics during the follow-up of breast cancer survivors.
  FULL TEXT PDF  

Keywords

atrial myxoma breast cancer cardiovascular imaging second primary tumor oncologic follow-up cardio-oncology




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Prophylactic use of intravascular balloon occlusion in elective general...
    2025, Vol.36, Núm. 1
  • Inflammation indices in chronic stable coronary artery disease
    2025, Vol.36, Núm. 1
  • Observational Registry for Cardiac Ablation in Atrial Fibrillation in Mexico...
    2025, Vol.36, Núm. 1
  • The MACARENHA connection: a holistic approach to understand and fight the...
    2025, Vol.36, Núm. 1
  • Statement from the Presidency of ANCAM and its Editorial Committee
    2025, Vol.36, Núm. 1
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 34, Num. 2, Abril-Junio 2023. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/